Cardiometabolic Risk Factors Registry

NCT04040777 | Recruiting

• 1 other identifier: 19-044
• Study Type: observational
• Target: 25,000
• Locations: 1 country
• Sites: 1

Brief Summary

CARFARE (CARDIOMETABOLIC RISK FACTORS REGISTRY) is a registry done in the context of a cardiovascular primary prevention program of the Cardiometabolic Unit Officia of the Cardiology Department of the Austral University Hospital. The structured and sequential evaluation include measurement of anthropometric parameters (body mass index, BMI), laboratory with metabolic profile, baseline electrocardiogram, blood pressure (BP) measurement, arterial stiffness, subclinical atherosclerosis screening in the carotid and ileo-femoral territories using echo-doppler, echocardiogram, and ergometry test.

Conditions

Atherosclerosis; Metabolic Syndrome; Diabetes; Cardiovascular Risk Factor; Cardiovascular Diseases; Obesity

Keywords

Subclinical Atherosclerosis; Metabolic Syndrome; Primary Prevention

Outcome Measures

Primary Outcomes (2)

• Incidence of Major Adverse Cardiovascular Events (MACE)

  Inicidence of myocardial infarction, stroke, unstable angina or acute heart failure

  5 years

• Mortality rate

  Death due to MACE or other causes

  5 years

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Primary prevention population. Most of the population are low and moderate cardiovascular risk.

You may qualify if:

• Age \>18 years old.

You may not qualify if:

• Previous cardiovascular and/or cerebrovascular event
• stable chronic angina
• advanced chronic kidney disease (Stage IV or V)
• cancer

Sponsors & Collaborators

• Austral University, Argentina: lead

Study Sites (1)

Hospital Universitario Austral

Pilar, Buenos Aires, 1631, Argentina

RECRUITING

MeSH Terms

Conditions

Atherosclerosis; Metabolic Syndrome; Diabetes Mellitus; Cardiovascular Diseases; Obesity

Condition Hierarchy (Ancestors)

Arteriosclerosis; Arterial Occlusive Diseases; Vascular Diseases; Insulin Resistance; Hyperinsulinism; Glucose Metabolism Disorders; Metabolic Diseases; Nutritional and Metabolic Diseases; Endocrine System Diseases; Overweight; Overnutrition; Nutrition Disorders; Body Weight; Signs and Symptoms; Pathological Conditions, Signs and Symptoms

Study Officials

• Maximo A Schiavone, MD

  Austral University, Argentina

  PRINCIPAL INVESTIGATOR

• Sergio Gonzalez, MD

  Austral University, Argentina

  STUDY DIRECTOR

Central Study Contacts

Maximo A Schiavone, MD

CONTACT

maximoschiavone@gmail.com

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: PROSPECTIVE
• Target Duration: 5 Years
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Coordinator of Clinical Research Department

Study Record Dates

• First Submitted: July 30, 2019
• First Posted: August 1, 2019
• Study Start: June 1, 2015
• Primary Completion (Estimated): December 1, 2030
• Study Completion (Estimated): December 1, 2030
• Last Updated: June 11, 2024

Record last verified: 2024-06

Data Sharing

• IPD Sharing: Will not share

Locations

AR (1)